AKT1 and hepatocellular carcinoma: Wang et al. reported ITGA2 may promote HCC progression by activating cell adhesion, migration, and survival pathways, such as FAK/PI3K/Akt pathway and modulating the interactions between tumor cells and their microenvironment [23].